Bin Wu

Bin Wu

Auto-generated profile, based on publicly available information

Bin Wu

Department of Neurology and National Research Center for Aging and Medicine & National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2019 in eLife
Verified
Journal Article
Open access
BWBin Wu
Bin Wu
FBFrançois Gc Blot
François Gc Blot
AWAaron Benson Wong
Aaron Benson Wong
COCatarina Osório
Catarina Osório
YAYouri Adolfs
Youri Adolfs
MSMartijn Schonewille
Martijn Schonewille
Despite the canonical homogeneous character of its organization, the cerebellum plays differential computational roles in distinct sensorimotor behaviors. Previously, we showed that Purkinje cell (PC) activity differs between zebrin-negative (Z–) and zebrin-positive (Z+) modules (Zhou et al., 2014). Here, using gain-of-function and loss-of-function mouse models, we show that transient receptor potential cation channel C3 (TRPC3) controls the simple spike activity of Z–, but not Z+ PCs. In addition, TRPC3 regulates complex spike rate and their interaction with simple spikes, exclusively in Z– PCs. At the behavioral level, TRPC3 loss-of-function mice show impaired eyeblink conditioning, which is related to Z– modules, whereas compensatory eye movement adaptation, linked to Z+ modules, is intact. Together, our results indicate that TRPC3 is a major contributor to the cellular heterogeneity that introduces distinct physiological properties in PCs, conjuring functional heterogeneity in cerebellar sensorimotor integration.

21 February 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
BWBin Wu
Bin Wu
WZWenli Zhang
Wenli Zhang
FPFangqiang Peng
Fangqiang Peng
MZMiaoyi Zhang
Miaoyi Zhang
BSBo Shen
Bo Shen
YZYue Zhang
Yue Zhang
In this report, we describe the case of a 37-year-old man presenting with intermittent episodes of dizziness and choreiform movements. MRI of the head showed an acute infarction in the left cerebellar hemisphere and multiple chronic infarctions in the cerebellum and pons. Vessel imaging also showed dynamic stenoses in the posterior circulation. This case provides a framework for evaluating young patients with intermittent dizziness and recurrent strokes and highlights the need to combine anatomical angiographies or hemodynamic studies with head rotational behavior.

1 November 2020 in Minerva Medica
Verified
Journal Article
Closed access
HJHaibo Jiang
Haibo Jiang
ZRZhaoyang Ruan
Zhaoyang Ruan
ZWZirong Wang
Zirong Wang
BWBin Wu
Bin Wu
ZGZhongming Gao
Zhongming Gao
XLXiaodong Lu
Xiaodong Lu
Article: Simvastatin reduces atherosclerotic plaques and endothelial inflammatory response in atherosclerosis rats through TGF-β/Smad pathway - Minerva Medica 2020 October;111(5):504-7 - Minerva Medica - Journals

23 April 2026 in Science
Verified
Journal Article
Closed access
LZLiansheng Zhang
Liansheng Zhang
QMQi Ma
Qi Ma
XKXiangrui Kong
Xiangrui Kong
WZWeijuan Zou
Weijuan Zou
BWBo Wang
Bo Wang
HZHaibo Zhou
Haibo Zhou
An in vivo approach combining high-throughput screening with cell type–specific readouts could enable elucidation of genotype-phenotype relationships in complex tissues. We developed an in vivo gain-of-function Perturb-seq platform, termed iGOF–Perturb-seq, to build a functional atlas of ~1000 transcription factors (TFs) in astrocytes, a cell type essential to many brain functions. We then identified cofunctional modules, annotated uncharacterized TFs, and predicted disease-associated TF clusters. Furthermore, iGOF–Perturb-seq performed in a mouse neuroinflammatory model identified Ferd3l as a therapeutic candidate, and astrocyte-specific overexpression of Ferd3l alleviated Alzheimer’s disease symptoms in mice. This study provides resources for understanding gene regulation and disease mechanisms in vivo and for identifying potential therapeutic targets for different brain diseases.

3 July 2026 in Science Advances
Verified
Journal Article
Open access
BSBo Shen
Bo Shen
LHLinlin Han
Linlin Han
YXYan Xiao
Yan Xiao
CSCong Shen
Cong Shen
ZLZiwei Le
Ziwei Le
Jian WangJian Wang
Jian Wang
The subthalamic nucleus (STN) is a prominent target for deep-brain stimulation (DBS) in the treatment of levodopa-induced dyskinesia (LID), a common motor complication of Parkinson’s disease. However, the precise impact of STN-DBS on LID remains unclear. Here, we investigated the functional roles of two distinct neuronal populations within the STN in regulating LID. In a mouse model of LID, STN neurons projecting to the entopeduncular nucleus (EP) exhibited a U-shaped activation pattern, whereas those projecting to the tegmental reticular nucleus (RtTg) displayed a predominantly inhibitory response. Activation of EP-projecting STN neurons alleviated dyskinesia but worsened hypokinesia in the parkinsonian state. Activation of RtTg-projecting STN neurons alone did not induce hyperkinetic characteristics, except when combined with levodopa. These findings reveal two anatomically and functionally distinct populations of STN neurons involved in LID regulation, offering insights into the circuitry underlying STN-DBS.

25 March 2024 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BWBin Wu
Bin Wu
LPLaura Post
Laura Post
ZLZhanmin Lin
Zhanmin Lin
MSMartijn Schonewille
Martijn Schonewille
Throughout life, the cerebellum plays a central role in the coordination and optimization of movements, using cellular plasticity to adapt a range of behaviors. Whether these plasticity processes establish a fixed setpoint during development, or continuously adjust behaviors throughout life, is currently unclear. Here, by spatiotemporally manipulating the activity of protein phosphatase 2B (PP2B), an enzyme critical for cerebellar plasticity, in male and female mice, we examined the consequences of disrupted plasticity on the performance and adaptation of the vestibulo-ocular reflex (VOR). We find that, in contrast to Purkinje cell specific deletion starting early postnatally, acute pharmacological as well as adult-onset genetic deletion of PP2B affects all forms of VOR adaptation, but not the level of VOR itself. Next, we show that Purkinje cell-specific genetic deletion of PP2B in juvenile mice leads to a progressive loss of the protein PP2B and a concurrent change in the VOR, in addition to the loss of adaptive abilities. Finally, re-expressing PP2B in adult mice that lack PP2B expression from early in development, rescues VOR adaptation, but does not affect the performance of the reflex. Together, our results indicate that chronic or acute, genetic or pharmacological block of PP2B disrupts the adaptation of the VOR. In contrast, only the absence of plasticity during cerebellar development affects the setpoint of VOR, an effect that cannot be corrected after maturation of the cerebellum. These findings suggest that PP2B-dependent cerebellar plasticity is required during a specific period to achieve the correct setpoint of the VOR.Significance StatementEarly damage to motor adaptation structures, such as the cerebellum, has been linked to neurodevelopmental disorders persisting into adulthood. Understanding these long-term effects requires disentangling the persistent effects of disrupted development from the acute effects directly caused by the continuous presence of the disruption. Here, we use the vestibulo-ocular reflex (VOR) to demonstrate that disruptions during early development affect both basal level and adaptation, whereas adult-onset disruption of cerebellar plasticity only affects the ability to adapt, not the setpoint of the reflex. Our findings that specifically the absence of plasticity during cerebellar development affects the setpoint of the VOR, which cannot be corrected by re-instating plasticity after maturation, supports the concept of a sensitive developmental period for setting cerebellum-controlled reflexes.